Trial Profile
A Phase 2 Study of Verubulin With Radiation Therapy and Temozolomide in Subjects Newly Diagnosed With Glioblastoma Multiforme.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Verubulin (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 25 Apr 2015 Results of incomplete analysis presented at the 67th Annual Meeting of the American Academy of Neurology.
- 08 Sep 2011 Status changed from recruiting to discontinued, as reported in a Myrexis media release.
- 22 Dec 2010 Status changed from planning to recruiting according to a Myrexis media release.